PXD046566

PXD046566 is an original dataset announced via ProteomeXchange.

Title	Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies
Description	Herein, we assembled a cohort composed of 254 CRC patients, including discovery cohort (N = 124) and validation cohort (N = 130), which received either chemotherapy (mainly FOLFOX therapy), chemoradiotherapy (mainly FOLFOX combined with radiotherapy), or targeted combination therapy (mainly FOLFOX combined with cetuximab).
HostingRepository	iProX
AnnounceDate	2023-10-30
AnnouncementXML	Submission_2024-02-26_19:51:06.464.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Yan Li
SpeciesList	scientific name: Homo sapiens; NCBI TaxID: 9606;
ModificationList	No PTMs are included in the dataset
Instrument	Q Exactive HF; Q Exactive HF-X

Revision	Datetime	Status	ChangeLog Entry
0	2023-11-01 00:23:08	ID requested
1	2023-11-01 00:23:41	announced
⏵ 2	2024-02-26 19:51:07	announced	2024-02-27: Update information.

Li Y, Wang B, Ma F, Jiang D, Wang Y, Li K, Tan S, Feng J, Wang Y, Qin Z, Xu G, Tian S, Zhang X, Xu C, Wu J, Xu J, Hou Y, Ding C, Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. Cell Rep Med, 4(12):101311(2023) [pubmed]

submitter keyword: Colorectal cancer, Proteomics, Chemotherapy

Chen Ding
contact affiliation	Fudan University
contact email	chend@fudan.edu.cn
lab head
Yan Li
contact affiliation	Fudan University
contact email	yanlee2020@126.com
dataset submitter

iProX dataset URI